
Preparing Health Systems for Multi-Cancer Early Detection | Exact Sciences
modernhealthcare.com/content-studio/white-paper/mh-preparing-health-systems-for-the-next-generation-of-cancer-screening/
Tel Aviv University plans to rename Sackler Faculty of Exact Sciences: The university said the change, made with the Sackler family’s approval ...
jpost.com/israel-news/culture/article-905046

Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance: Abbott stock took a hit early Thursday on lackluster guidance for the year and second quarter ...
investors.com/news/technology/abbott-laboratories-stock-abbott-laboratories-earnings-q1-2026/

Abbott trims 2026 profit forecast on Exact deal hit, shares fall: Medical device maker now expects adjusted profit per share between US$5.38 and US$5.58 ...
theglobeandmail.com/business/article-abbott-trims-2026-profit-forecast-on-exact-deal-hit-shares-fall/
The deal brings Exact Sciences' flagship screening test for colorectal cancer, Cologuard, under Abbott's umbrella ... Show more
Abbott closes $23 billion deal to buy Madison-based Exact Sciences
Abbott closes $23 billion deal to buy Madison-based Exact Sciences

Cologuard Classic raises colon cancer awareness while providing safe space for survivors
sbnation.com/golf/1107079/cologuard-classic-awareness-survivors-pga-tour-champions

Abbott kicks off bond sale for Exact Sciences deal : Abbott’s recent focus has been on medical devices, with its glucose monitors driving growth.
modernhealthcare.com/medical-devices/mh-abbott-laboratories-bond-sale-exact-sciences/
Paid articlePaywall Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.: Abbott Laboratories agrees to buy the cancer screening company Exact Sciences in ...
barrons.com/articles/exact-sciences-stock-abbott-acquisition-92c76a15

Abbott is buying Exact Sciences. Here’s why
modernhealthcare.com/medical-devices/mh-abbott-laboratories-exact-sciences-robert-ford/

The Minnesotan behind Cologuard, which fueled the biggest health care acquisition of 2025
startribune.com/abbott-acquisition/601536926

Medical technology: Abbott buys Exact Sciences: US medical technology group Abbott is acquiring cancer testing provider Exact Sciences for around $23 billion ...
wiwo.de/unternehmen/industrie/medizintechnik-abbott-kauft-exact-sciences/100176698.html

This CEO Just Sold His Company for $21 Billion. It Wouldn’t Have Happened Without Federally Funded Research
inc.com/stephanie-mehta/this-ceo-just-sold-his-company-for-21-billion-it-wouldnt-have-happened-without-federally-funded-research/91266552

Exact Sciences Catapults On $23 Billion Abbott Labs Buyout: Exact Sciences stock rocketed for a second day Thursday, after Abbott Laboratories confirmed a $23 ...
investors.com/news/technology/exact-sciences-stock-abbott-laboratories-rumored-takeover/
Paid articlePaywall Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test
marketwatch.com/story/why-abbott-is-paying-21-billion-for-exact-sciences-and-its-cologuard-cancer-test-43dd31f9
Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer is a colonoscopy ... Show more
Madison's Exact Sciences' $23 billion sale is tied to its Cologuard cancer test. What to know
Madison's Exact Sciences' $23 billion sale is tied to its Cologuard cancer test. What to know

Abbott to buy Madison-based Exact Sciences in deal valued at up to $23 billion: The deal will add the cancer test Cologuard to Abbott's portfolio.
eu.jsonline.com/story/news/2025/11/20/abbott-to-buy-madison-based-exact-sciences-in-up-to-23-billion-deal/87370349007/

Paid articlePaywall Abbott To Complete $21B M&A Deal For Exact Sciences - What Investors Should Know: Exact Sciences Corporation stock surged after Abbott Laboratories announces a ...
seekingalpha.com/article/4846214-abbott-to-complete-21bn-m-and-a-deal-for-exact-sciences-what-investors-should-know

Senators spar over ACA subsidies, HSAs at hearing: Republicans are closing ranks around expanding health savings accounts rather than extending exchange plan ...
modernhealthcare.com/politics-regulation/mh-senate-finance-committee-hsa-aca-subsidies/

Celeb-backed Function Health valued at $2.5B after $298M Series B
modernhealthcare.com/health-tech/mh-function-health-funding-matt-damon-zac-efron/

WVU Health to acquire Independence, invest $800M in upgrades: The deal is expected to close in fall 2026, pending regulatory approval and bondholder consent.
modernhealthcare.com/providers/mh-independence-health-west-virginia-university-medicine/

Providence eliminates more than 400 positions in 2 states: The cuts are due to ongoing financial challenges, including those stemming from policy and regulatory ...
modernhealthcare.com/providers/staffing/mh-providence-swedish-layoffs-elizabeth-wako/

Abbott is weighing takeover of Exact Sciences, Bloomberg News reports: Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test ...
reuters.com/business/healthcare-pharmaceuticals/abbott-is-weighing-takeover-exact-sciences-bloomberg-news-reports-2025-11-19/

Why Medicaid insurers are struggling: Medicaid margins are dwindling as health insurers such as Centene and UnitedHealthcare report rising costs.
modernhealthcare.com/insurance/mh-unitedhealth-group-centene-elevance-medicaid/

OIA’s CEO plots growth in imaging partnerships with hospitals: Outpatient Imaging Affiliates President and CEO Amy Stout said joint ventures are part of the ...
modernhealthcare.com/providers/mh-outpatient-imaging-affiliates-amy-stout-piedmont/
Multi-cancer early detection (MCED) testing is opening new possibilities in cancer screening and preventive care.
In this exclusive video interview ... Show more
One-on-One with David Harding of Exact Sciences
One-on-One with David Harding of Exact Sciences

How a Texas congressman won support for a controversial cancer test: Experts worry early detection tests like Galleri and CancerGuard are unproven and could ...
houstonchronicle.com/politics/texas/article/cancer-tests-mced-arrington-legislation-21073610.php
How can health systems detect cancer earlier and more proactively? In this One-on-One, Exact Sciences’ David Harding explores how MCED testing could reshape ... Show more
Modern Healthcare
Modern Healthcare
Multi-cancer early detection (MCED) tests are reshaping what’s possible in cancer screening and prevention. In this exclusive conversation ... Show more
Modern Healthcare
Modern Healthcare

He got an at-home colon cancer test in the mail. The problem? He doesn't have a colon.
eu.usatoday.com/story/news/health/2025/10/12/why-colon-cancer-tests-mailed-to-homes/86192537007/

Exact Sciences Tumbles On Plans To License Blood-Based Colon Cancer Test: Exact Sciences stock crashed Wednesday after the company inked a deal for the exclusive ...
investors.com/news/technology/exact-sciences-stock-exact-sciences-earnings-q2-2025-freenome-blood-test/

Exact Sciences Rises After Key FDA Win: Exact Sciences stock rose Friday after the FDA approved the company's next-generation colon cancer detection test ...
investors.com/news/technology/exact-sciences-stock-cologuard-plus-approved/

US FDA approves Guardant Health's blood-based cancer test - News | Khaleej Times: The test, known as Shield, has been available in the US as a ...
khaleejtimes.com/world/us-fda-approves-guardant-healths-blood-based-cancer-test

Wisconsin lands $49 million in funding for medical sciences: Wisconsin lands $49 million in funding for medical sciences, personalized medicine.
jsonline.com/story/money/business/2024/07/02/wisconsin-lands-49-million-in-funding-for-medical-sciences/74278410007/

Guardant Soars On A Key Colon Cancer Win; Exact Sciences Dives: Guardant Health stock rocketed Friday after an FDA panel recommended the agency approve ...
investors.com/news/technology/guardant-health-stock-fda-advisory-committee-blood-based-colon-cancer-screening-test-shield/

This Cathie Wood's Play Just Hit A 7-Month High On A Rival's News: Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome ...
investors.com/news/technology/exact-sciences-stock-cologuard-freenome-colon-cancer-detection/

Radiopharma Space Heats Up As Biotech Rockets 97% on $2 Billion Deal: AstraZeneca said Tuesday is would acquire Fusion Pharmaceuticals for $2 billion upfront ...
investors.com/news/technology/fusion-pharmaceuticals-astrazeneca-acquisition-biotech-stock/